Simeprevir
Showing 1 - 25 of 127
Male Infertility, HCV Trial in Al Qalyubiyah, Banha (Sofosbuvir +daclatasvir+ simeprevir+Ribavirin)
Recruiting
- Male Infertility
- HCV
- Sofosbuvir +daclatasvir+ simeprevir+Ribavirin
-
Al Qalyūbīyah, Benha, Egypt
- +1 more
Nov 7, 2022
HIV, Hepatitis C Trial in Aurora (dolutegravir, simeprevir)
Completed
- HIV
- Hepatitis C
- dolutegravir
- simeprevir
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Feb 23, 2021
Hepatitis C Trial in Denver (Simeprivir (SMV), Sofosbuvir (SOF), Ribavirin (RBV))
Terminated
- Hepatitis C
- Simeprivir (SMV)
- +2 more
-
Denver, ColoradoUniversity of Colorado Denver (Leprino Building)
Aug 16, 2021
Chronic Hepatitis C Virus Infection Trial (Sofosbuvir + Simeprevir + Ribavirin)
Completed
- Chronic Hepatitis C Virus Infection
- Sofosbuvir + Simeprevir + Ribavirin
- (no location specified)
May 9, 2020
Against HCV Based on Direct-acting Antivirals in Real-life
Completed
- Chronic Hepatitis C Infection
- Telaprevir
- +10 more
-
Seville, Andalusia, SpainValme University Hospital
Jun 22, 2022
Chronic Hepatitis C Virus Infection Trial in Bani Sweif (SOF/SMV/DCV/RBV)
Completed
- Chronic Hepatitis C Virus Infection
-
Bani Sweif, EgyptHealth Administration at Beni-Seuf
May 10, 2020
Hepatitis C Trial in Worldwide (No Treatment)
Terminated
- Hepatitis C
- No Treatment
-
Vancouver, British Columbia, Canada
- +10 more
May 12, 2020
Hepatitis C, Chronic Trial in Japan (AL-335, Odalasvir (ODV), Simeprevir (SMV))
Hepatitis C, Chronic, HIV CDC Category A1 Trial in San Francisco (Sofosbuvir + Simeprevir)
Withdrawn
- Hepatitis C, Chronic
- HIV CDC Category A1
- Sofosbuvir + Simeprevir
-
San Francisco, CaliforniaSan Francisco General Hospital, University of California, San Fr
Jun 11, 2019
Hepatitis C, Chronic Trial in Belgium (Simeprevir (SMV), Ledipasvir (LDV), Sofosbuvir (SOF))
Completed
- Hepatitis C, Chronic
- Simeprevir (SMV)
- +2 more
-
Antwerpen, Belgium
- +3 more
Mar 27, 2019
Hepatitis C, Chronic Trial in San Antonio (Simeprevir, Daclatasvir, Sofosbuvir)
Completed
- Hepatitis C, Chronic
- Simeprevir
- +2 more
-
San Antonio, Texas(unnamed)
Apr 24, 2019
Chronic Hepatitis C Infection Trial in Beijing, Hong Kong (PR4 + LDV/SOF + ASV 4 wk, PR4 + LDV/SOF + SMV 4 wk, PR4 + LDV/SOF +
Recruiting
- Chronic Hepatitis C Infection
- PR4 + LDV/SOF + ASV 4 wk
- +7 more
-
Beijing, Beijing, China
- +1 more
Aug 27, 2021
HCV-TARGET- Hepatitis C Therapeutic Registry and Research
Active, not recruiting
- Hepatitis C
-
Phoenix, Arizona
- +59 more
Oct 5, 2022
Hepatitis C Trial in Darlinghurst, Sydney, Adelaide (Sofosbuvir 400mg [Sovaldi], Glecaprevir/pibrentasvir (300mg/120mg))
Recruiting
- Hepatitis C
- Sofosbuvir 400mg [Sovaldi]
- Glecaprevir/pibrentasvir (300mg/120mg)
-
Darlinghurst, New South Wales, Australia
- +2 more
Mar 28, 2022
Hepatitis C, Medication Adherence Trial in Greenville (Intensive Models (mDOT and CGT) of HCV Care)
Completed
- Hepatitis C
- Medication Adherence
- Intensive Models (mDOT and CGT) of HCV Care
-
Greenville, South CarolinaGreenville Health System
Mar 26, 2021
RIBAvirin Plasma COncentrations in Chronic Hepatitis C Infection
Completed
- HCV Coinfection
- Hepatitis C
-
Nijmegen, Gelderland, NetherlandsRadboud University Medical Centre
Dec 4, 2020
Hepatitis C and HIV Coinfection Trial in Aurora (Blood draws for tenofovir PK, renal function)
Completed
- Hepatitis C and HIV Coinfection
- Blood draws for tenofovir PK, renal function
-
Aurora, ColoradoUniversity of Colorado Hospital
Aug 10, 2021
Impact of Antiviral Therapy on Gastroesophageal Varices.
Completed
- Chronic Hepatitis C
- Cirrhosis
- Pegylated interferon alfa-2a + Ribavirin
- +6 more
- (no location specified)
May 18, 2018